Research Article
Primary Gastric Lymphoma: Conservative Treatment Modality Is Not Inferior to Surgery for Early-Stage Disease
Table 2
Clinical characteristics of study patients ().
| | | | Non-MALT
() | MALT
() |
| Age
(years, median (range)) | | 53 (43–63) | 56 (32–80) | | Gender ( (%)) | Male | 28 (45%) | 9 (56%) | | Female | 34 (55%) | 7 (44%) | | Stage ( (%)) | I/II, IIE | 44 (71%) | 13 (81%) | | IV | 19 (29%) | 3 (19%) | Karnofsky performance status
( (%)) | ≥80 | 56 (89%) | 12 (75%) | | <80 | 7 (11%) | 4 (25%) | | LDH level ( (%)) | >240 mg | 26 (42%) | 9 (56%) | | Normal range | 28 (45%) | 5 (31%) | | Unknown | 9 (13%) | 2 (13%) |
|
|
MALT: mucosa associated lymphoid tissue, LDH: lactate dehydrogenase.
|
